Scientists have discovered that early-life cardiac injury in parents can alter heart development and function in offspring, leading to improved cardiac remodeling and increased blood ejection volume. This finding suggests a potential long-term impact on cardiovascular health.
The American Heart Association invites communities nationwide to walk together on National Walking Day to break the cycle of sedentary behavior. Regular walking can improve both physical and mental well-being, even in small steps.
Researchers Schmidt and Selvin will explore the connections between cardiovascular disease and diabetes, with a focus on large white blood cells and wearable continuous glucose monitors. Their work aims to develop new treatment therapies and improve health outcomes for people with diabetes.
A new study found that compound heatwaves significantly increase cardiac mortality and are more impactful than traditional binary definitions of heatwaves.
Research shows that highly reactive components in particulate matter disappear within hours, leading to inaccurate estimates of their presence and potential health risks. This discovery highlights the need for more accurate measurements and better protective measures.
Swedish researchers have identified 20 genetic variants associated with an increased risk of atherosclerosis, a leading cause of cardiovascular disease. The study used advanced imaging techniques to examine millions of genetic variants, providing new insights into the disease process and potential ways to prevent it.
A new method combines ECGI with digital twins to locate the origin of premature ventricular contractions, improving accuracy by an average of 7.8 mm. The method has been applied in a real clinical case and is expected to facilitate planning interventions and reduce treatment costs.
Dr. David Winchester will lead the American College of Cardiology's Board of Governors, guiding chapters representing all 50 states and promoting heart health improvement in communities. His term aims to address practice challenges through advocacy and chapter support.
A recent study found substantial rural-urban disparities in cardiometabolic risk factors and cardiovascular diseases among US adults. Social risk factors are identified as the primary driver of these disparities, with efforts to address socioeconomic conditions in rural communities critical to reducing the gap.
A new study has found that clopidogrel outperforms aspirin monotherapy in reducing heart attack rates without increasing bleeding risk in high-risk patients following percutaneous coronary intervention (PCI). Researchers observed a significant reduction in ischemic endpoints, primarily driven by a decrease in heart attacks.
A new transcatheter valve has shown high survival rates and improved quality of life in patients with aortic regurgitation. The trial found an overall mortality rate of 8.1% at one year, meeting non-inferiority to open heart surgery outcomes.
A new study by Intermountain Health finds that peripheral artery disease is often underdiagnosed and undertreated, particularly in women. The condition affects nearly 10% of the US population and has a high mortality rate, with patients having a 50% chance of dying from it.
The BHF PROTECT-TAVI trial found no reduction in stroke rate for patients undergoing TAVR with an embolic protection device. Despite its large sample size, the study showed that cerebral embolic protection devices do not improve outcomes for TAVR patients.
Patients who received nurse-led follow-up care had a 30% lower rate of cardiovascular death, non-fatal heart attacks, or strokes at five years compared to those receiving standard care. This was achieved through improved lifestyle habits and medication adherence.
A new mobile integrated health program delivered in-home visits from paramedic teams to people with heart failure did not significantly reduce hospital readmissions or improve health status compared to standard follow-up phone calls. However, the study found that women and younger patients may benefit more from this intervention.
A minimally invasive procedure using a clip to repair the tricuspid valve significantly reduced symptom severity and decreased recurrent hospitalization for heart failure. The study found a 28% reduction in hospitalizations at two years, with improved safety and effectiveness compared to medical therapy alone.
Patients with severe triple-vessel heart disease showed no significant difference in outcomes between CABG and PCI at five years. The FAME-3 trial enrolled 1,500 patients with triple-vessel disease and found that both procedures performed similarly well, considering recent advances in surgical and minimally invasive techniques.
A study found that semaglutide significantly improved maximal walking distance in people with symptomatic peripheral artery disease (PAD) and Type 2 diabetes. Patients taking semaglutide also experienced improvements in symptoms and quality of life compared to those on a placebo.
A study presented at the American College of Cardiology's Annual Scientific Session found that dapagliflozin significantly reduced the rate of worsening heart failure in elderly patients with heart failure undergoing transcatheter aortic valve replacement. The trial, called DapaTAVI, enrolled 1,257 patients and showed a 28% lower rate ...
An AI model has been developed to detect blocked coronary arteries based on ECG readings, achieving high accuracy and outperforming expert clinicians. The model could help physicians quickly identify patients who require urgent treatment for a heart attack.
In an open-label study, patients hospitalized for a serious heart attack who received rivaroxaban or warfarin had similar efficacy and safety outcomes. Rivaroxaban showed comparable results in dissolving left ventricular blood clots at three months follow-up.
A new clinical trial found that oral semaglutide can significantly reduce cardiovascular events in people with type 2 diabetes and pre-existing cardiovascular disease. The medication decreased the risk of major cardiac events by 14% compared to placebo, with nonfatal myocardial infarction seeing the greatest reductions in risk.
A study published in JAMA Cardiology found that legislation to reduce sodium in processed food in South Africa is linked to significant declines in blood pressure levels. The reduction in sodium intake has been associated with lower rates of cardiovascular disease mortality and stroke, potentially saving millions of lives globally.
A four-year study presented at the American College of Cardiology's Annual Scientific Session found that oral semaglutide reduced cardiovascular death, heart attack, and stroke by 14% compared to a placebo. The drug's benefits are comparable to injectable forms and offer an alternative for patients who prefer not to take injections.
A Phase 2b trial found lorundrostat significantly reduced blood pressure in patients with uncontrolled hypertension by 7.9 mm Hg and 6.5 mm Hg compared to placebo at 12 weeks. The drug showed an acceptable side effect profile, with consistent patterns across secondary endpoints.
The American College of Cardiology will honor three early career cardiologists with the Hani Najm Global Scholar Award Observership Program at ACC.25, taking place in Chicago. The program encourages international cardiology professionals to share knowledge and enhance their training by shadowing a practicing cardiologist in the US.
The American College of Cardiology has recognized 21 distinguished award recipients for their outstanding contributions to the field of cardiovascular medicine. The awardees will be honored during Convocation at ACC.25 in Chicago, showcasing their remarkable work in transforming cardiovascular care and improving heart health.
The American College of Cardiology has recognized 10 young researchers with the Young Author Achievement Award, showcasing their groundbreaking work published in JACC journals. The awardees will be recognized during ACC.25 in Chicago, March 29-31, 2025.
The American College of Cardiology recognizes Jennifer Mateo Soto and Opeyemi Olalekan Oni for their innovative cardiovascular research projects in low- and middle-income countries. The awardees will receive $25,000 to support their research, which aims to improve the care of people at risk or living with cardiovascular disease.
The American Heart Association has launched a new certification program for hospitals dedicated to optimizing heart failure treatment, reducing readmissions. The Heart Failure Center Certification aims to enhance patient outcomes and promote evidence-based treatments.
Many teenagers enter adulthood with significant risk factors for cardiovascular disease, and emerging adulthood is a key time to address these risks. Interventions such as health practices, lifestyle changes, and improved access to healthcare can help reduce the risk of developing future cardiovascular disease.
The rate of maternal mortality related to cardiovascular causes has more than doubled between 1999 and 2022 in the US. Researchers attribute the increase to factors such as socioeconomic disadvantages, limited access to healthcare, and higher prevalence of risk factors.
People with heart failure who can travel outside their home without assistance are less likely to be hospitalized or die within a year. Life-space mobility, a measure of how far patients move in their communities, is a reliable marker of risk for adverse outcomes in chronic diseases.
A study of 130 volunteers found a drastic decrease in heart rate variability after COVID-19, even in mild cases. The researchers observed an imbalance between the sympathetic and parasympathetic nervous systems, suggesting a higher risk of adverse cardiovascular outcomes.
A study published in Nutrients found that men and women eat differently, with women taking longer to finish meals and chewing more. Increasing the number of chews per bite and taking smaller bites can extend meal duration, which is positively associated with reduced food consumption.
A remote booster program after cardiac rehabilitation significantly reduces daily sitting time and increases light physical activity, lowering the risk of cardiovascular diseases. Participants who received coaching via phone and digital communication showed a clear improvement in sedentary behavior and increased physical activity.
Researchers developed SenePy, a powerful new software platform that identifies aging cells in organs and tissues. The tool helps analyze genetic signatures distinguishing senescent cells from their healthier neighbors, enabling the study of cellular senescence and its role in diseases such as cancer, heart attacks, and brain inflammation.
A new study finds a positive correlation between microplastic concentration and the prevalence of high blood pressure, diabetes, stroke, but not cancer. Higher microplastic pollution is associated with a higher risk of disease, suggesting a potential link between microplastics and chronic noncommunicable diseases.
A growing body of evidence suggests a significant link between human papillomavirus (HPV) and heart disease. Researchers pooled data from nearly 250,000 patients in seven studies, finding HPV-positive individuals had a 40% higher likelihood of developing cardiovascular disease.
Chronic kidney disease rates increased by 24% globally from 1990 to 2021, linked to higher cardiovascular disease risk. Collaborative care and screening for cardiovascular-kidney-metabolic syndrome can reduce mortality and improve patient lives.
A large study suggests that patients at high risk of heart attacks and strokes should be treated immediately with a combination of a statin and ezetimibe, rather than statins alone. This combination therapy significantly reduces the risk of death from any cause and major adverse cardiovascular events.
A Swedish study of over 1,300 participants found that losing a significant amount of weight still offers protection against health issues like cancer and cardiovascular disease, even if some weight is regained. However, regaining weight can increase the risk of microvascular disease and other health problems.
A new study by Uppsala University found that coffee machines in workplaces frequently produce coffee with high levels of cholesterol-elevating substances, which can affect LDL cholesterol levels and future cardiovascular disease risk. Regular drip-filter coffee makers filter out most of these substances.
TCT 2025 will take place October 25-28, 2025, at the Moscone Center in San Francisco, California. The event will feature acute interventions, breakthrough technologies, and cutting-edge research driving the next era of cardiovascular care.
A new study suggests that dividing average daily heart rate by steps taken per day provides a more reliable indicator of cardiovascular fitness. People with elevated DHRPS were twice as likely to have Type 2 diabetes and more than 1.5 times as likely to have high blood pressure compared to those with lower DHRPS.
A recent study has found that people diagnosed with colorectal cancer are more likely to die from cardiovascular causes, particularly in the first two years after diagnosis. The study analyzed data from over 630,000 US adults and found a 16% increased risk of cardiovascular mortality among those with colorectal cancer.
Two Indian hospitals, Apollo Hospital in Hyderabad and Aster Hospital in Calicut, have been certified as Comprehensive Stroke Centers by the American Heart Association. These centers meet rigorous standards for stroke care, including advanced imaging and treatment capabilities. This certification is part of the Association's efforts to...
A deep learning model analyzes breast arterial calcification and translates results into a cardiovascular risk score, helping identify patients at higher risk of heart disease. The tool is particularly useful for younger women, who can benefit from early interventions.
A study found that women who underwent bilateral oophorectomy were more likely to develop heart failure later in life. The researchers suggest that early menopause may be a contributing factor to this increased risk, and recommend closer cardiovascular monitoring for women contemplating the procedure.
Scientists have developed a low-cost and easy-to-use diagnostic tool for assessing cardiovascular disease risk using molecular blood screening. The technology enables high-throughput analysis of key lipoprotein markers in under 15 minutes, providing clinicians with a rapid and reliable diagnostic tool.
The American Heart Association and Buffalo Bills are working together to bring Hands-Only CPR and AED training to community events and youth sports groups. This effort aims to double sudden cardiac arrest survival rates by 2030, with over 200 CPR & First Aid in Youth Sports training kits distributed.
Hyperuricemia is a metabolic disorder characterized by elevated uric acid levels, linked to cardiovascular diseases, gout, renal dysfunction, and metabolic disorders. Advances in technology and genetic research are transforming management strategies, including personalized treatments and probiotic interventions.
The review explores the pathophysiological mechanisms linking obstructive sleep apnea syndrome and metabolic syndrome, highlighting recent advancements in therapeutic strategies. Treatment approaches aim to break the harmful cycle between OSA and MetS, which affects approximately 14% of the global population.
A study found that a healthy plant-based diet was associated with a 17-24% lower risk of death from any cause, cardiovascular disease or cancer. Researchers analyzed data from nearly 78,000 people with cardiometabolic disorders and found that closer adherence to a healthful plant-based diet brought significant benefits.
Researchers at the University of Virginia Health System have developed a computational tool called LogiRx that can predict how drugs will affect biological processes in the body. The tool has demonstrated its potential by identifying a promising candidate to prevent heart failure, a leading cause of death worldwide.
Researchers found that lifestyle and health factors linked with heart disease have a stronger impact on women than men. Women were more likely to have fewer negative risk factors but faced a greater increase in cardiovascular events if they had more negative risk factors compared to men.
Two new studies have found a substantial link between cannabis use and an increased risk of heart attack. The studies, one retrospective and one meta-analysis, pooled data from over 4.6 million people, showing that cannabis users under the age of 50 were six times more likely to suffer a heart attack than non-users.
A longitudinal study of Hispanic mothers found that women with normal blood pressure levels during pregnancy but no mid-pregnancy drop in blood pressure face an increased risk of developing hypertension after giving birth. Tracking blood pressure patterns during pregnancy may help identify these women and prevent cardiovascular disease.
A new study by Penn State researchers found that consuming pecans instead of usual snacks improved cholesterol levels and enhanced overall diet quality. Participants who ate pecans demonstrated reductions in cholesterol measurements linked to poorer heart health and higher adherence to the Dietary Guidelines for Americans.
SourcePenn State·JournalAmerican Journal of Clinical Nutrition·TypeRandomized controlled/clinical trial·DateMar 17, 2025
Research published in the European Heart Journal suggests that Australia's burden of cardiovascular disease caused by extreme heat will more than double by 2050. The study found that hot weather costs around 49,483 years of healthy life annually, with this number expected to increase significantly under climate change scenarios.